As on Wednesday, MBX Biosciences Inc (NASDAQ: MBX) got off with the flyer as it spiked 8.69% to $19.52, before settling in for the price of $17.96 at the close. Taking a more long-term approach, MBX posted a 52-week range of $4.81-$27.50.
Nevertheless, stock’s Earnings Per Share (EPS) this year is 54.08%. This publicly-traded company’s shares outstanding now amounts to $33.59 million, simultaneously with a float of $26.70 million. The organization now has a market capitalization sitting at $872.85 million. At the time of writing, stock’s 50-day Moving Average stood at $14.66, while the 200-day Moving Average is $11.72.
MBX Biosciences Inc (MBX) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Biotechnology industry. MBX Biosciences Inc’s current insider ownership accounts for 40.30%, in contrast to 48.66% institutional ownership. According to the most recent insider trade that took place on Oct 20 ’25, this organization’s President & CEO bought 20,000 shares at the rate of 13.64, making the entire transaction reach 272,790 in total value, affecting insider ownership by 468,277. Preceding that transaction, on Oct 17 ’25, Company’s Director bought 20,000 for 13.25, making the whole transaction’s value amount to 264,984. This particular insider is now the holder of 20,000 in total.
MBX Biosciences Inc (MBX) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.66 per share during the current fiscal year.
MBX Biosciences Inc’s EPS increase for this current 12-month fiscal period is 54.08% and is forecasted to reach -2.71 in the upcoming year.
MBX Biosciences Inc (NASDAQ: MBX) Trading Performance Indicators
Let’s observe the current performance indicators for MBX Biosciences Inc (MBX). It’s Quick Ratio in the last reported quarter now stands at 19.50.
In the same vein, MBX’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -2.31, a figure that is expected to reach -0.69 in the next quarter, and analysts are predicting that it will be -2.71 at the market close of one year from today.
Technical Analysis of MBX Biosciences Inc (MBX)
Through scrutinizing the latest numbers posted by the [MBX Biosciences Inc, MBX], it can be observed that its last 5-days Average volume of 0.9 million was better the volume of 0.6 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 91.40% While, its Average True Range was 75.86.
Raw Stochastic average of MBX Biosciences Inc (MBX) in the period of the previous 100 days is set at 59.21%, which indicates a major fall in contrast to 95.09% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 1.21 that was lower than 1.36 volatility it exhibited in the past 100-days period.
